Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion
Clinical trial NCT01740531 · COMPLETED
Trial details
- NCT number
- NCT01740531
- Sponsor
- Cerus Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-12-21
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.